Intimation of Press Release.

Date: 07-11-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam, Subject: Intimation of Press Release In terms of Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of Press Release being issued by the Company on the following subject: “Mukka Proteins Reports Strong Q2 FY27 Performance Oman Facility Commences Commercial Production U.S. FDA Facility Registration Strengthens Market Access USDA NOP Inputs Attestation for Eco Sphere Organic Fertilizer” This is for your information and records. Thank you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502 Encl: as above. Mukka Proteins Reports Strong Q2 FY27 Performance Oman Facility Commences Commercial Production U.S. FDA Facility Registration Strengthens Market Access USDA NOP Inputs Attestation for Eco Sphere Organic Fertilizer Q2 FY27 Revenue increases 108.06% YoY to ₹ 5,088.70 Mn Q2 FY27 PAT at ₹ 177.27 Mn, up 157.51% YoY Mangalore, November 07, 2026: Mukka Proteins Limited (“the Company”), one of India’s prominent manufacturers and exporters of fishmeal, fish oil, and fish‑soluble paste and engaged in waste‑to‑value solutions, announced its Financial Results for the second quarter and half year ended September 30, 2026. Consolidated Financial Performance: Q2 FY27 v/s Q1 FY27 (QoQ) Q2 FY27 v/s Q2 FY26 (YoY) Revenue: ₹ 5,088.70 Mn against ₹ 4,896.54 Mn Revenue: ₹ 5,088.70 Mn against ₹ 2,445.81 Mn Gross Profit: ₹ 895.64 Mn against ₹ 1,078.00 Gross Profit: ₹ 895.64 Mn against ₹ 559.05 Mn Gross Profit Margin: 17.60% against 22.02% Gross Profit Margin: 17.60% against 22.86% EBITDA: ₹ 501.18 Mn against ₹ 486.23 Mn EBITDA: ₹ 501.18 Mn against ₹ 262.77 Mn EBITDA Margin: 9.85% against 9.93% EBITDA Margin: 9.85% against 10.74% PAT: ₹ 177.27 Mn against ₹ 186.34 Mn PAT: ₹ 177.27 Mn against ₹ 68.84 Mn PAT Margin: 3.48% against 3.81% PAT Margin: 3.48% against 2.81% Standalone Financial Performance: Q2 FY27 v/s Q1 FY27 Q2 FY27 v/s Q2 FY26 Revenue: ₹ 4,115.42 Mn against ₹ 4,058.56 Mn Revenue: ₹ 4,115.42 Mn against ₹ 2,222.71 Mn Gross Profit: ₹ 614.90 Mn against ₹ 814.85 Mn Gross Profit: ₹ 614.90 Mn against ₹ 425.42 Mn Gross Profit Margin: 14.94% against 20.08% Gross Profit Margin: 14.94% against 19.14% EBITDA: ₹ 357.53 Mn against ₹ 441.36 Mn EBITDA: ₹ 357.53 Mn against ₹ 193.87 Mn EBITDA Margin: 8.69% against 10.87% EBITDA Margin: 8.69% against 8.72% PAT: ₹ 106.99 Mn against ₹ 194.07 Mn PAT: ₹ 106.99 Mn against ₹ 36.10 Mn PAT Margin: 2.60% against 4.78% PAT Margin: 2.60% against 1.62% Note: Amounts are presented in ₹ Mn. Consolidated Quarterly Performance Revenue from operations for Q2 FY27 stood at ₹5,088.70 Mn, registering a robust 108.06% YoY growth. EBITDA increased to ₹ 501.18 Mn, up 90.73% YoY, while EBITDA margin stood at 9.85%. PAT stood at ₹ 177.27 Mn, compared to ₹ 68.84 Mn in Q2 FY26 with YoY growth of 157.51 %, while PAT margin expanded to 3.48 %. Growth was supported by strong export demand, improved realisations and favourable industry dynamics amid global fishmeal supply constraints. However, geopolitical disruptions and supply-chain constraints resulted in the execution of certain shipments being deferred to October 2026. Standalone Quarterly Performance Revenue from operations for Q2 FY27 stood at ₹ 4,115.42 Mn, reflecting a strong 85.15 % YoY growth. EBITDA increased to ₹ 357.53 Mn, up 84.41% YoY, with EBITDA margin declining by 3 bps YoY to 8.69%. PAT rose to ₹ 106.99 Mn from ₹ 36.10 Mn in Q1 FY26 with YoY growth of 196.37%, while PAT margin expanded by 98 bps YoY to 2.60%. Key Business Highlights: • Capacity Expansion: Oman Facility Commences Commercial Production: The commencement of commercial production by United Gulf Fishery Products LLC for fishmeal, fish oil and fish-soluble paste has increased the Group’s overall production capacity and strengthened its manufacturing presence in the Middle East. The expanded capacity enhances the Group’s ability to address demand across international markets and capitalise on prevailing supply constraints in the global fishmeal industry. The existing manufacturing capacity has increased from 291,720 MTPA to 340,170 MTPA, following the addition of capacities from United Gulf Fishery Products LLC and Delta Marine Products, as detailed below: United Gulf Fishery Products LLC: 37,200 MTPA (Fish Meal: 24,000 MT, Fish Oil: 6,000 MT and Fish Soluble Paste: 7,200 MT) Delta Marine Products: 11,250 MTPA (Fish Meal) • USDA NOP Inputs Attestation received for Eco Sphere Organic Fertilizer: ECOCERT S.A.S., France confirmed that the product Eco Sphere Organic Fertilizer suitable for use in organic farming. The attestation is expected to support product acceptance in organic-farming markets, including the United States. • U.S. FDA facility registration secured: The Company’s facility registration with the U.S. Food and Drug Administration supports engagement with customers and markets that require U.S. FDA- registered manufacturing facilities. • CARE Ratings revised the outlook to Stable from Negative: CARE Ratings assigned CARE BBB−; Stable / CARE A3 to ₹480 crore of long-term and short-term bank facilities and CARE BBB−; Stable to ₹15 crore of long-term bank facilities. The Stable outlook reflects improved operating performance, steady demand and expectations of better inventory and liquidity metrics. Mr. Kalandan Mohammed Haris, CEO & MD, Mukka Proteins Limited, said, “Q2 FY27 was another period of strong execution for Mukka Proteins. We delivered healthy growth across the quarter and first half, supported by strong demand in export markets, favourable fishmeal pricing and improved product realisations. Our performance reflects the strength of our procurement network, integrated operations and ability to serve customers consistently across markets. However, geopolitical disruptions and industry-wide supply-chain constraints affected shipment schedules, resulting in the execution of certain shipments being deferred to October 2026. During the quarter, we commenced commercial production at the Al Juba facility in Oman, increasing the Group’s overall production capacity and strengthening our manufacturing presence in the Middle East. With operations at the facility now underway, we are well positioned to progressively ramp up production, serve international customers more efficiently and capitalise on the prevailing demand- supply dynamics in the global fishmeal industry. We also secured U.S. FDA facility registration and received USDA NOP Inputs Attestation from ECOCERT S.A.S., France, for Eco Sphere Organic Fertilizer. These milestones enhance our regulatory readiness, support access to markets with specific registration requirements and expand the opportunity set for our sustainable product portfolio. We continued to strengthen the foundation of our integrated animal protein and sustainability platform. Our alignment with the MarinTrust Improver Programme reinforces our focus on responsible sourcing and traceable supply chains, while the integration of Ento Proteins, Haris Marine Products and Delta Marine Products broadens our manufacturing and alternate-protein capabilities. The integrated animal waste management contract further advances our waste-to-value strategy. Looking ahead, our immediate priorities include ramping up operations at the Al Juba facility, executing the shipments deferred to October, deepening market access and improving operating efficiencies across the Group. The additional capacity from United Gulf Fishery Products LLC positions us to respond to favourable demand-supply dynamics and scale our presence across international markets. We also remain focused on scaling our diversified businesses acro [Showing first 8,000 characters — download PDF for full document]